| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |